Active substance
Results for the substance laronidase
2 results
About this active substance
Laronidase is an enzyme used for the treatment of mucopolysaccharidosis type I (MPS I), a rare genetic disorder caused by the accumulation of glycosaminoglycans in the body. It works by replacing the deficient enzyme, helping to reduce the buildup of harmful substances.
The medication is administered intravenously, usually once a week, under the supervision of a specialist. It is important to monitor the patient's reactions during the infusion.
Side effects may include infusion site reactions, fever, headache, or nausea. In rare cases, severe allergic reactions such as anaphylaxis may occur.
Laronidase is not recommended for patients with hypersensitivity to this medication or any of its components.
The medication is administered intravenously, usually once a week, under the supervision of a specialist. It is important to monitor the patient's reactions during the infusion.
Side effects may include infusion site reactions, fever, headache, or nausea. In rare cases, severe allergic reactions such as anaphylaxis may occur.
Laronidase is not recommended for patients with hypersensitivity to this medication or any of its components.